M&A/IPOs

 

Ramsay Sante’s Capio integration and finances paint a puzzling picture

It's been nearly two years since Australian-owned French hospital group Ramsay Sante completed the acquisition of Nordic-French acute care operator Capio. Contacts give HBI their assessment of how the integration is going and we take a look at Capio's performance since it was acquired. 

Korian shares dive 10% as it announces capital raise for Inicea deal

Shares in pan-European elderly care group Korian dived by 10% after it announced a €400m capital raise to fund the acquisition of France's third-largest psychiatry provider Inicea from infrastructure investor Antin. But did it pay over-the-odds and do all shareholders support the capital raise? We talk to an analyst from Bryan, Garnier & Co.

Healthcare Activos internationalises with Portuguese acquisition and French listing

REIT Healthcare Activos Yield has listed on the Euronext Access Paris, while its sister company Healthcare Activos has made its first acquisition outside of Spain, CEO of the management company for both tells HBI. He talks us through the listing and the long-term impact of COVID-19 on the development of the Spanish care home sector.

Regulator: ‘Politics played no role’ in Mehilainen-Pihlajalinna decision

The Finnish Competition and Consumer Authority's (FCCA) surprise decision to oppose the merger of Mehilainen and Pihlajalinna has nothing to do with the changing political climate around the privatisation of healthcare, its merger control director tells HBI. She also explains why you can't compare it to the merger of Terveystalo and Attendo in 2018. 

CDPQ joins EQT on Colisée acquisition

The Canadian pension fund CDPQ is co-investing alongside EQT in the acquisition of French nursing home operator Colisée, its second investment in the European healthcare sector.

Hapvida and Intermedica continue M&A binge through crisis

Brazilian listed HMOs (health management organisations) Hapvida Saude and Grupo Notre Dame Intermedica have resumed their M&A binge since July after a quiet second quarter, despite the pandemic continuing to rage throughout the country. 

Eugin process enters second-round – but will COVID impact valuation?

Sell-side advisors Perella Weinburg have shortlisted a dozen second-rounder bidders for Eugin, the global IVF arm of NMC Health, according to reports in Spain. A source tells HBI Eugin's recent figures have been significantly impacted by COVID - will it impact the valuation?

Find Us